Short Interest in GMO Beyond China ETF (NYSEARCA:BCHI) Grows By 192.5%

GMO Beyond China ETF (NYSEARCA:BCHI) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 1,129 shares, an increase of 192.5% from the November 30th total of 386 shares. Based on an average trading volume of 1,532 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.3% of the company’s shares are sold short. Approximately 0.3% of the company’s shares are sold short. Based on an average trading volume of 1,532 shares, the days-to-cover ratio is presently 0.7 days.

GMO Beyond China ETF Stock Performance

BCHI stock traded up $0.06 during midday trading on Friday, reaching $30.98. The company’s stock had a trading volume of 384 shares, compared to its average volume of 4,624. GMO Beyond China ETF has a 1 year low of $21.81 and a 1 year high of $30.98. The firm has a market capitalization of $12.39 million, a price-to-earnings ratio of 14.75 and a beta of 1.37. The stock has a fifty day simple moving average of $30.20 and a two-hundred day simple moving average of $28.96.

Institutional Investors Weigh In On GMO Beyond China ETF

A hedge fund recently bought a new stake in GMO Beyond China ETF stock. Lazard Asset Management LLC acquired a new stake in GMO Beyond China ETF (NYSEARCA:BCHI) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 20,851 shares of the company’s stock, valued at approximately $570,000. Lazard Asset Management LLC owned 5.21% of GMO Beyond China ETF at the end of the most recent reporting period.

GMO Beyond China ETF Company Profile

The GMO Beyond China ETF (BCHI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed to invest in equity securities of any market capitalization from emerging markets, with the exemption of China. BCHI was launched on Feb 12, 2025 and is issued by GMO.